{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:31:48Z","timestamp":1793298708091,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2023CX02"],"award-info":[{"award-number":["2023CX02"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2024CX08"],"award-info":[{"award-number":["2024CX08"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2024YC24"],"award-info":[{"award-number":["2024YC24"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22407008"],"award-info":[{"award-number":["22407008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277002"],"award-info":[{"award-number":["22277002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["5006604"],"award-info":[{"award-number":["5006604"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["2244082"],"award-info":[{"award-number":["2244082"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["Z220014"],"award-info":[{"award-number":["Z220014"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L248067"],"award-info":[{"award-number":["L248067"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF0501400"],"award-info":[{"award-number":["2021YFF0501400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.eururo.2025.03.010","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:10:00Z","timestamp":1744175400000},"page":"717-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["First-in-human Study of a Dual-modality Prostate-specific Membrane Antigen\u2013targeted Probe for Preoperative Positron Emission Tomography\/Computed Tomography Imaging and Intraoperative Fluorescence Imaging in Prostate Cancer"],"prefix":"10.1016","volume":"87","author":[{"given":"Silu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2025.03.010_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2025.03.010_b0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2013.07.039","article-title":"Positive surgical margins after radical prostatectomy: a systematic review and contemporary update","volume":"65","author":"Yossepowitch","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.03.010_b0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.euo.2019.03.006","article-title":"Defining clinically meaningful positive surgical margins in patients undergoing radical prostatectomy for localised prostate cancer","volume":"4","author":"Martini","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.03.010_b0020","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2025.03.010_b0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.03.010_b0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.eururo.2022.06.002","volume":"82","author":"Gandaglia","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.03.010_b0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eururo.2022.03.002","article-title":"Robot-assisted prostate-specific membrane antigen-radioguided salvage surgery in recurrent prostate cancer using a DROP-IN gamma probe: the first prospective feasibility study","volume":"82","author":"de Barros","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.03.010_b0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(23)00102-X","article-title":"First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial","volume":"24","author":"Stibbe","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2025.03.010_b0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.euo.2023.07.004","volume":"7","author":"Nguyen","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.03.010_b0050","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00259-024-06713-x","article-title":"First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy","volume":"51","author":"Hamdy","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eururo.2025.03.010_b0055","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1002\/anie.201102872","article-title":"Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen","volume":"50","author":"Banerjee","year":"2011","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.eururo.2025.03.010_b0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2967\/jnumed.117.201293","article-title":"PSMA-11-derived dual-labeled PSMA inhibitors for preoperative PET imaging and precise fluorescence-guided surgery of prostate cancer","volume":"59","author":"Baranski","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.eururo.2025.03.010_b0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2967\/jnumed.118.212720","article-title":"Synthesis and preclinical characterization of the PSMA-targeted hybrid tracer PSMA-I&F for nuclear and fluorescence imaging of prostate cancer","volume":"60","author":"Schottelius","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.eururo.2025.03.010_b0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2967\/jnumed.119.233064","article-title":"Hybrid tracers based on cyanine backbones targeting prostate-specific membrane antigen: tuning pharmacokinetic properties and exploring dye-protein interaction","volume":"61","author":"Hensbergen","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.eururo.2025.03.010_b0075","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1007\/s00259-023-06492-x","article-title":"A novel PSMA targeted dual-function near-infrared fluorescence and PET probe for the image-guided surgery and detection of prostate cancer","volume":"51","author":"Fu","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eururo.2025.03.010_b0080","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2967\/jnumed.120.248443","article-title":"Rational linker design to accelerate excretion and reduce background uptake of peptidomimetic PSMA-targeting hybrid molecules","volume":"62","author":"Eder","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.eururo.2025.03.010_b0085","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2967\/jnumed.114.138180","article-title":"Dual-modality image-guided surgery of prostate cancer with a radiolabeled fluorescent anti-PSMA monoclonal antibody","volume":"55","author":"Lutje","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.eururo.2025.03.010_b0090","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1021\/acs.bioconjchem.4c00292","article-title":"Preclinical evaluation of a PSMA aptamer-based bifunctional PET and fluorescent probe","volume":"35","author":"Kong","year":"2024","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.eururo.2025.03.010_b0095","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00259-020-05184-0","article-title":"The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET\/CT and intraoperative fluorescence imaging","volume":"48","author":"Eder","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eururo.2025.03.010_b0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.clgc.2021.03.011","article-title":"Small molecule, multimodal, [(18)F]-PET and fluorescence imaging agent targeting prostate-specific membrane antigen: first-in-human study","volume":"19","author":"Aras","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2025.03.010_b0105","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/acs.jmedchem.9b02031","article-title":"(S)-3-(carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic acid as a novel PSMA targeting scaffold for prostate cancer imaging","volume":"63","author":"Duan","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.eururo.2025.03.010_b0110","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00259-021-05486-x","article-title":"(68)Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent","volume":"49","author":"Duan","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eururo.2025.03.010_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116810","article-title":"Optimization of ODAP-urea-based dual-modality PSMA targeting probes for sequential PET-CT and optical imaging","volume":"66","author":"Li","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.eururo.2025.03.010_b0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.03.010_b0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/pros.24799","article-title":"Head-to-head comparison of GA-68 PSMA PET\/CT and multiparametric MRI findings with postoperative results in preoperative locoregional staging and localization of prostate cancer","volume":"85","author":"Dinckal","year":"2025","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2025.03.010_b0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/end.2024.0586","article-title":"Robot-assisted radical prostatectomy using the KangDuo Surgical Robot-1500: a prospective, multicenter, single-arm clinical study","volume":"39","author":"Chen","year":"2025","journal-title":"J Endourol"},{"key":"10.1016\/j.eururo.2025.03.010_b0135","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.euf.2024.05.023","article-title":"Robot-assisted radical prostatectomy with the KangDuo surgical system versus the da Vinci Si System: a prospective, double-center, randomized controlled trial","volume":"10","author":"Shen","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2025.03.010_b0140","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1158\/1078-0432.CCR-19-4156","article-title":"First-in-human assessment of cRGD-ZW800-1, a zwitterionic, integrin-targeted, near-infrared fluorescent peptide in colon carcinoma","volume":"26","author":"de Valk","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2025.03.010_b0145","unstructured":"FDA. Tetle 21, Code of federal regulations, part 361: radioactive drugs for certain research uses. 1985."},{"key":"10.1016\/j.eururo.2025.03.010_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1030187","article-title":"Preclinical evaluation and first in human study of Al(18)F radiolabeled ODAP-urea-based PSMA targeting ligand for PET imaging of prostate cancer","volume":"12","author":"Ren","year":"2022","journal-title":"Front Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825001824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825001824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:30:23Z","timestamp":1762288223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283825001824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0302283825001824"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2025.03.010","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-in-human Study of a Dual-modality Prostate-specific Membrane Antigen\u2013targeted Probe for Preoperative Positron Emission Tomography\/Computed Tomography Imaging and Intraoperative Fluorescence Imaging in Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2025.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}